Marc Machnik
Overview
Explore the profile of Marc Machnik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eichler F, Ehrle A, Machnik M, Jensen K, Wagner S, Baudisch N, et al.
Front Vet Sci
. 2024 Jan;
10:1305873.
PMID: 38234983
As a remedy against stress and anxiety, cannabidiol (CBD) products are of increasing interest in veterinary medicine. Limited data is available describing the actual effectiveness of CBD in horses. The...
2.
Eichler F, Pozniak B, Machnik M, Schenk I, Wingender A, Baudisch N, et al.
Front Vet Sci
. 2023 Aug;
10:1234551.
PMID: 37621871
Cannabidiol (CBD) products gain increasing popularity amongst animal owners and veterinarians as an alternative remedy for treatment of stress, inflammation or pain in horses. Whilst the use of cannabinoids is...
3.
Schenk I, Broussou D, Roques B, Lagershausen H, Machnik M, Rottgen H, et al.
Drug Test Anal
. 2023 Feb;
15(6):629-645.
PMID: 36806946
The combination of sulfadoxine (SDO) with trimethoprim (TMP) is widely used in veterinarian medicine. The aim of the present study was to compare excretion profiles and detection time windows of...
4.
Schenk I, Machnik M, Broussou D, Meuly A, Roques B, Lallemand E, et al.
J Vet Pharmacol Ther
. 2021 Jun;
44(5):733-744.
PMID: 34115414
In horses, the benzodiazepine diazepam (DIA) is used as sedative for pre-medication or as an anxiolytic to facilitate horse examinations. As the sedative effects can also be abused for doping...
5.
Paine S, Bright J, Scarth J, Hincks P, Pearce C, Hannan C, et al.
J Vet Pharmacol Ther
. 2020 Feb;
43(2):162-170.
PMID: 32012314
In equine and racing practice, detomidine and butorphanol are commonly used in combination for their sedative properties. The aim of the study was to produce detection times to better inform...
6.
Barton A, Heinemann H, Schenk I, Machnik M, Gehlen H
Am J Vet Res
. 2017 Feb;
78(2):244-250.
PMID: 28140635
OBJECTIVE To evaluate the influence of respiratory tract disease (ie, recurrent airway obstruction [RAO]) and mode of inhalation on detectability of inhaled budesonide in equine plasma and urine samples. ANIMALS...
7.
Buntenkotter K, Osmers M, Schenk I, Schanzer W, Machnik M, Due M, et al.
BMC Vet Res
. 2017 Jan;
13(1):28.
PMID: 28103874
Background: Although acetylsalicylic acid (ASA) is not frequently used as a therapeutic agent in horses, its metabolite SA is of special interest in equestrianism since it is a natural component...
8.
Machnik M, Kaiser S, Koppe S, Kietzmann M, Schenk I, Due M, et al.
Drug Test Anal
. 2016 Sep;
9(9):1372-1384.
PMID: 27662634
Methylxanthines positives in competition samples have challenged doping control laboratories and racing jurisdictions since methylxanthines are naturally occurring prohibited substances and often constituents of feed. For theobromine, an international threshold...
9.
Moller I, Thomas A, Wingender A, Machnik M, Schanzer W, Thevis M
Eur J Mass Spectrom (Chichester)
. 2012 Sep;
18(4):407-12.
PMID: 22971699
Erythropoietin (EPO) and its recombinant analogues are suspected to be illicitly administered to horses for performance enhancing purposes and, consequently, prohibited in equine sports. Recently, a new erythropoiesis-stimulating agent, peginesatide...
10.
Palm F, Schenk I, Neuhauser S, Schubert D, Machnik M, Schanzer W, et al.
Theriogenology
. 2010 May;
74(2):229-35.
PMID: 20452000
Treatment with the progestin altrenogest is widely used in pregnant mares. The fact that foals born from healthy mares treated with altrenogest until term suffered from neonatal problems raises the...